题名 | The MAPK and AMPK signalings: interplay and implication in targeted cancer therapy |
作者 | |
发表日期 | 2020-08-17
|
DOI | |
发表期刊 | |
ISSN | 1756-8722
|
EISSN | 1756-8722
|
卷号 | 13期号:1 |
摘要 | Cancer is characterized as a complex disease caused by coordinated alterations of multiple signaling pathways. The Ras/RAF/MEK/ERK (MAPK) signaling is one of the best-defined pathways in cancer biology, and its hyperactivation is responsible for over 40% human cancer cases. To drive carcinogenesis, this signaling promotes cellular overgrowth by turning on proliferative genes, and simultaneously enables cells to overcome metabolic stress by inhibiting AMPK signaling, a key singular node of cellular metabolism. Recent studies have shown that AMPK signaling can also reversibly regulate hyperactive MAPK signaling in cancer cells by phosphorylating its key components, RAF/KSR family kinases, which affects not only carcinogenesis but also the outcomes of targeted cancer therapies against the MAPK signaling. In this review, we will summarize the current proceedings of how MAPK-AMPK signalings interplay with each other in cancer biology, as well as its implications in clinic cancer treatment with MAPK inhibition and AMPK modulators, and discuss the exploitation of combinatory therapies targeting both MAPK and AMPK as a novel therapeutic intervention. |
关键词 | |
相关链接 | [Scopus记录] |
收录类别 | |
语种 | 英语
|
重要成果 | ESI高被引
|
学校署名 | 第一
|
资助项目 | Asia Fund for Cancer Research[AFCR-2017/2019JH]
; SingHealth Foundation[AM/TP011/2018]
; NMRC[OFIRG18nov-0078]
|
WOS研究方向 | Oncology
; Hematology
|
WOS类目 | Oncology
; Hematology
|
WOS记录号 | WOS:000563183100001
|
出版者 | |
Scopus记录号 | 2-s2.0-85089643433
|
来源库 | Scopus
|
引用统计 |
被引频次[WOS]:271
|
成果类型 | 期刊论文 |
条目标识符 | http://sustech.caswiz.com/handle/2SGJ60CL/153301 |
专题 | 南方科技大学第一附属医院 |
作者单位 | 1.Department of Urology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, 518020, Guangdong, China 2.Geriatric Department, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, 518020, Guangdong, China 3.Shenzhen People's Hospital,Shenzhen,1017 Dongmen North Road,518020,China 4.Cancer and Stem Cell Program,Duke-NUS Medical School,8 College Road,169857,Singapore 5.Division of Cellular and Molecular Research,National Cancer Centre Singapore ,11 Hospital Drive,169610,Singapore |
第一作者单位 | 南方科技大学第一附属医院 |
第一作者的第一单位 | 南方科技大学第一附属医院 |
推荐引用方式 GB/T 7714 |
Yuan,Jimin,Dong,Xiaoduo,Yap,Jiajun,et al. The MAPK and AMPK signalings: interplay and implication in targeted cancer therapy[J]. Journal of Hematology & Oncology,2020,13(1).
|
APA |
Yuan,Jimin,Dong,Xiaoduo,Yap,Jiajun,&Hu,Jiancheng.(2020).The MAPK and AMPK signalings: interplay and implication in targeted cancer therapy.Journal of Hematology & Oncology,13(1).
|
MLA |
Yuan,Jimin,et al."The MAPK and AMPK signalings: interplay and implication in targeted cancer therapy".Journal of Hematology & Oncology 13.1(2020).
|
条目包含的文件 | 条目无相关文件。 |
|
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论